BRCA1 gene-related hereditary susceptibility to breast and ovarian cancer in Latvia-Reference-Cited by-同舟云学术

BRCA1 gene-related hereditary susceptibility to breast and ovarian cancer in Latvia

Published:2014-03 Issue:1 Volume:59 Page:114-119
ISSN:1896-1126
Container-title:Advances in Medical Sciences
language:en
Short-container-title:Advances in Medical Sciences

Author:

Tihomirova Laima,Vaivade Iveta,Fokina Oksana,Peculis Raitis,Mandrika Ilona,Sinicka Olga,Stengrevics Aivars,Krilova Anna,Keire Guntars,Petrevics Janis,Eglitis Janis,Timofejevs Mihails,Leja Marcis

Funder

European Social Fund

Latvian Science Council

Publisher

Elsevier BV

Subject

General Medicine

Reference34 articles.

1. Common BRCA1 and BRCA2 mutations in breast cancer families: a meta-analysis from systematic review;Wang;Mol Biol Rep,2012

2. BRCA mutations in the management of breast cancer: the state of the art;Narod;Clin Oncol,2010

3. High frequency of BRCA1 founder mutations in Polish women with nonfamilial breast cancer;Gaj;Fam Cancer,2012

4. Genetic epidemiology of BRCA mutations – family history detects less than 50% of the mutation carriers;Møller;Eur J Cancer,2007

5. Prevalence of BRCA1/2 mutations, in sporadic breast/ovarian cancer patients and identification of a novel de novo BRCA1 mutation in a patient diagnosed with late onset breast and ovarian cancer: implications for genetic testing;De Leeneer;Breast Cancer Res Treat,2012

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Molecular Detection of Germline Mutations in the BRCA1 and BRCA2 Genes Associated with Breast and Ovarian Cancer in a Romanian Cohort of 616 Patients;Current Issues in Molecular Biology;2024-05-12

2. Analysis of pathogenic variants in BRCA1 and BRCA2 genes using next-generation sequencing in women with triple negative breast cancer from South India;Molecular Biology Reports;2022-01-12

3. A novel frequent BRCA1 recurrent variant c.5117G > A (p.Gly1206Glu) identified after 20 years of BRCA1/2 research in the Baltic region: cohort study and literature review;Hereditary Cancer in Clinical Practice;2021-01-19

4. High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population;Hereditary Cancer in Clinical Practice;2018-06-05